Key result
Delayed-enhanced MRI enables noninvasive quantification of myocardial fibrosis in severe aortic valve disease.
Why the study?
Assessment of interstitial myocardial fibrosis and myocyte degeneration in chronic aortic valve disease has been limited to histological analyses of myocardial biopsy fragments, while delayed-enhancement MRI has recently shown potential for accurate fibrosis assessment.
Does delayed-enhanced MRI accurately quantify myocardial fibrosis compared to quantified histopathology in patients with severe aortic valve disease?
Observational
Does delayed-enhanced MRI accurately quantify myocardial fibrosis compared to quantified histopathology in patients with severe aortic valve disease?
Delayed-enhanced MRI is being evaluated as a non-invasive alternative to endomyocardial biopsy for assessing myocardial fibrosis in severe aortic valve disease.
Answers are grounded in this paper and cite their sources.
No quantitative results reported; leaves open whether delayed-enhanced MRI accurately quantifies fibrosis versus histopathology in severe aortic valve disease.
Chronic aortic valve disease is characterized by progressive accumulation of interstitial myocardial fibrosis (MF) and impairment of myocyte ultrastructure. The amount of interstitial MF may play an important role in the transition from well-compensated hypertrophy to overt heart failure in the setting of chronic LV mechanical overload. However, assessment of interstitial MF and myocyte degeneration has only been possible through histological analyses of myocardial fragments from endomyocardial biopsies. Recently, delayed-enhancement magnetic resonance imaging (deMRI) has been shown to provide an accurate assessment of myocardial necrosis and fibrosis.
No takes yet. Share an insight, caveat, or question.
Rochitte et al. (2009) conducted an observational in Severe aortic valve disease. Delayed-enhanced MRI (deMRI) vs. Quantified histopathology was evaluated on Quantification of myocardial fibrosis. Delayed-enhanced MRI was investigated for the quantification of myocardial fibrosis in patients with severe aortic valve disease, but the abstract reports no quantitative results.
Synapse has enriched 10 related papers. Consider them for comparative context: